BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CP, Andraus W, Alves VA, Leclercq I. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025-1048. [PMID: 26047667 DOI: 10.1007/s00204-015-1543-4] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 15.4] [Reference Citation Analysis]
Number Citing Articles
1 De Muynck K, Vanderborght B, Van Vlierberghe H, Devisscher L. The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021;10:2959. [PMID: 34831182 DOI: 10.3390/cells10112959] [Reference Citation Analysis]
2 Zhou T, Glaser SS. Pleiotropic effects of CD5L in hepatic inflammation and fibrosis. EBioMedicine 2019;44:22-3. [PMID: 31151931 DOI: 10.1016/j.ebiom.2019.05.039] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Pesce A, Ciurleo R, Bramanti A, Armeli Iapichino EC, Petralia MC, Magro GG, Fagone P, Bramanti P, Nicoletti F, Mangano K. Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis. Molecules 2020;25:E4310. [PMID: 32962198 DOI: 10.3390/molecules25184310] [Reference Citation Analysis]
4 Azzam M, El Safy S, Abdelgelil SA, Weiskirchen R, Asimakopoulou A, de Lorenzi F, Lammers T, Mansour S, Tammam S. Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers. Pharmaceutics 2020;12:E590. [PMID: 32630415 DOI: 10.3390/pharmaceutics12060590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Romualdo GR, Prata GB, da Silva TC, Evangelista AF, Reis RM, Vinken M, Moreno FS, Cogliati B, Barbisan LF. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation. J Nutr Biochem 2020;85:108479. [PMID: 32795656 DOI: 10.1016/j.jnutbio.2020.108479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H. Inflammasomes and Fibrosis. Front Immunol 2021;12:643149. [PMID: 34177893 DOI: 10.3389/fimmu.2021.643149] [Reference Citation Analysis]
7 Kataoka S, Umemura A, Okuda K, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y, Arbiser JL, Shima T, Okanoue T, Itoh Y. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells. Int J Mol Sci 2021;22:13354. [PMID: 34948151 DOI: 10.3390/ijms222413354] [Reference Citation Analysis]
8 Wu HY, Zhang XC, Jia BB, Cao Y, Yan K, Li JY, Tao L, Jie ZG, Liu QW. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R/PI3K/AKT signaling pathway. J Pharmacol Sci 2021;147:143-55. [PMID: 34294366 DOI: 10.1016/j.jphs.2021.06.008] [Reference Citation Analysis]
9 Tabernilla A, Dos Santos Rodrigues B, Pieters A, Caufriez A, Leroy K, Van Campenhout R, Cooreman A, Gomes AR, Arnesdotter E, Gijbels E, Vinken M. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. Int J Mol Sci 2021;22:5038. [PMID: 34068678 DOI: 10.3390/ijms22095038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
11 Lurje I, Hammerich L, Tacke F. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. Int J Mol Sci 2020;21:E7378. [PMID: 33036244 DOI: 10.3390/ijms21197378] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
12 Yang B, Zhang J, Sun L, Huang T, Kong Y, Li L, Sun Z, Yin M, Li X. Mapping Novel Biomarkers of Liver Injury by Tissue Proteomic Analysis. ACS Omega 2021;6:7127-38. [PMID: 33748626 DOI: 10.1021/acsomega.1c00152] [Reference Citation Analysis]
13 Meng F, Khoso MH, Kang K, He Q, Cao Y, Jiang X, Xiao W, Li D. FGF21 ameliorates hepatic fibrosis by multiple mechanisms. Mol Biol Rep 2021;48:7153-63. [PMID: 34536190 DOI: 10.1007/s11033-021-06707-0] [Reference Citation Analysis]
14 Lagares D, Hinz B. Animal and Human Models of Tissue Repair and Fibrosis: An Introduction. Methods Mol Biol 2021;2299:277-90. [PMID: 34028750 DOI: 10.1007/978-1-0716-1382-5_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cabriales L, Hautefeuille M, Vázquez‐victorio G, Martinez‐pastor D, Carretero‐ortega J, Jiménez‐escobar A, Macias‐silva M. Hepatic C9 cells switch their behaviour in short or long exposure to soft substrates. Biol Cell 2020;112:265-79. [DOI: 10.1111/boc.201900115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khomich O, Ivanov AV, Bartosch B. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells 2019;9:E24. [PMID: 31861818 DOI: 10.3390/cells9010024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
17 Qin T, Fu J, Verkade HJ. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation. Hum Genet 2021;140:709-24. [PMID: 32920649 DOI: 10.1007/s00439-020-02221-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tibaldi E, Brocca A, Sticca A, Gola E, Pizzi M, Bordin L, Pagano MA, Mazzorana M, Donà G, Violi P, Marin O, Romano A, Angeli P, Carraro A, Brunati AM. Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis. FASEB J 2020;34:1122-35. [PMID: 31914633 DOI: 10.1096/fj.201900880R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Wang PW, Wu TH, Lin TY, Chen MH, Yeh CT, Pan TL. Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis. Cells 2019;8:E1184. [PMID: 31581522 DOI: 10.3390/cells8101184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Klaunig JE, Li X, Wang Z. Role of xenobiotics in the induction and progression of fatty liver disease. Toxicol Res (Camb) 2018;7:664-80. [PMID: 30090613 DOI: 10.1039/c7tx00326a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
22 Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Reference Citation Analysis]
23 Sha M, Gao Y, Deng C, Wan Y, Zhuang Y, Hu X, Wang Y. Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice. Int Immunopharmacol 2020;79:106157. [PMID: 31911372 DOI: 10.1016/j.intimp.2019.106157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
24 Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol 2016; 22(48): 10512-10522 [PMID: 28082803 DOI: 10.3748/wjg.v22.i48.10512] [Cited by in CrossRef: 198] [Cited by in F6Publishing: 182] [Article Influence: 33.0] [Reference Citation Analysis]
25 Sharma A, Verma AK, Kofron M, Kudira R, Miethke A, Wu T, Wang J, Gandhi CR. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors. Hepatology 2020;72:1800-18. [PMID: 32064648 DOI: 10.1002/hep.31188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Hassan R, Tammam SN, Safy SE, Abdel-halim M, Asimakopoulou A, Weiskirchen R, Mansour S. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis. European Journal of Pharmaceutics and Biopharmaceutics 2019;134:96-106. [DOI: 10.1016/j.ejpb.2018.11.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
27 Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW. Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. J Exp Pharmacol 2018;10:9-17. [PMID: 29785143 DOI: 10.2147/JEP.S150729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
28 Devaraj E, Roy A, Royapuram Veeraragavan G, Magesh A, Varikalam Sleeba A, Arivarasu L, Marimuthu Parasuraman B. β-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1067-75. [PMID: 31930431 DOI: 10.1007/s00210-020-01810-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
29 Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, Guo XL, He HW. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin 2020;42:1808-20. [PMID: 34465912 DOI: 10.1038/s41401-021-00754-w] [Reference Citation Analysis]
30 Hajny S, Christoffersen C. A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. Int J Mol Sci 2017;18:E1636. [PMID: 28749426 DOI: 10.3390/ijms18081636] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
31 Königshofer P, Brusilovskaya K, Schwabl P, Reiberger T. Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis 2019;1865:1019-30. [PMID: 30055295 DOI: 10.1016/j.bbadis.2018.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. [PMID: 28506744 DOI: 10.1016/j.addr.2017.05.007] [Cited by in Crossref: 359] [Cited by in F6Publishing: 356] [Article Influence: 71.8] [Reference Citation Analysis]
33 Svinka J, Pflügler S, Mair M, Marschall HU, Hengstler JG, Stiedl P, Poli V, Casanova E, Timelthaler G, Sibilia M, Eferl R. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis. J Mol Med (Berl) 2017;95:109-17. [PMID: 27568040 DOI: 10.1007/s00109-016-1462-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
34 Yan L, Messner CJ, Zhang X, Suter-Dick L. Assessment of fibrotic pathways induced by environmental chemicals using 3D-human liver microtissue model. Environ Res 2021;194:110679. [PMID: 33387535 DOI: 10.1016/j.envres.2020.110679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Li T, Liu J, Wang Y, Zhou C, Shi Q, Huang S, Yang C, Chen Y, Bai Y, Xiong B. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model. Sci Rep 2021;11:22846. [PMID: 34819565 DOI: 10.1038/s41598-021-02155-9] [Reference Citation Analysis]
36 Chung AS, Mettlen M, Ganguly D, Lu T, Wang T, Brekken RA, Hsiehchen D, Zhu H. Immune Checkpoint Inhibition is Safe and Effective for Liver Cancer Prevention in a Mouse Model of Hepatocellular Carcinoma. Cancer Prev Res (Phila) 2020;13:911-22. [PMID: 32839204 DOI: 10.1158/1940-6207.CAPR-20-0200] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Song LJ, Yin XR, Mu SS, Li JH, Gao H, Zhang Y, Dong PP, Mei CJ, Hua ZC. The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice. Front Immunol 2020;11:570524. [PMID: 33117360 DOI: 10.3389/fimmu.2020.570524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Song N, Xu H, Liu J, Zhao Q, Chen H, Yan Z, Yang R, Luo Z, Liu Q, Ouyang J, Wu S, Luo S, Ye S, Lin R, Sun X, Xie J, Lan T, Wu Z, Wang R, Jiang X. Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis. Acta Pharmaceutica Sinica B 2021. [DOI: 10.1016/j.apsb.2021.12.016] [Reference Citation Analysis]
39 Ke B, Lee C. Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines. Journal of Functional Foods 2018;43:214-23. [DOI: 10.1016/j.jff.2018.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 Yang J, Gong Y, Xu W, Li L, Shi Z, Wang Q, He Y, Zhang C, Luo C, Fang Z, Yang Y. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1779-86. [PMID: 34191114 DOI: 10.1007/s00210-021-02114-1] [Reference Citation Analysis]
41 Long T, Wang L, Yang Y, Yuan L, Zhao H, Chang C, Yang G, Ho C, Li S. Protective effects of trans -2,3,5,4′-tetrahydroxystilbene 2- O -β- d -glucopyranoside on liver fibrosis and renal injury induced by CCl 4via down-regulating p-ERK1/2 and p-Smad1/2. Food Funct 2019;10:5115-23. [DOI: 10.1039/c9fo01010f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Ge H, Wang A, Su Y, Yu C, Gao L, Li Y. Ameliorative effects of Qingganjiuwei powder, a traditional Mongolian medicine, against CCl4-induced liver fibrosis in rats. J Ethnopharmacol 2021;264:113226. [PMID: 32829054 DOI: 10.1016/j.jep.2020.113226] [Reference Citation Analysis]
43 Orbach SM, Ford AJ, Saverot SE, Rajagopalan P. Multi-cellular transitional organotypic models to investigate liver fibrosis. Acta Biomater 2018;82:79-92. [PMID: 30316024 DOI: 10.1016/j.actbio.2018.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Wimborne HJ, Takemoto K, Woster PM, Rockey DC, Lemasters JJ, Zhong Z. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice. Free Radic Biol Med 2019;145:136-45. [PMID: 31557514 DOI: 10.1016/j.freeradbiomed.2019.09.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 Rouchon A, Pécheur EI. [Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice]. Med Sci (Paris) 2017;33:856-9. [PMID: 28994379 DOI: 10.1051/medsci/20173310014] [Reference Citation Analysis]
46 Chen T, Lin H, Chen X, Li G, Zhao Y, Zheng L, Shi Z, Zhang K, Hong W, Han T. LncRNA Meg8 suppresses activation of hepatic stellate cells and epithelial-mesenchymal transition of hepatocytes via the Notch pathway. Biochemical and Biophysical Research Communications 2020;521:921-7. [DOI: 10.1016/j.bbrc.2019.11.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
47 Yuan L, Jiang J, Liu X, Zhang Y, Zhang L, Xin J, Wu K, Li X, Cao J, Guo X, Shi D, Li J, Jiang L, Sun S, Wang T, Hou W, Zhang T, Zhu H, Zhang J, Yuan Q, Cheng T, Li J, Xia N. HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation. Gut 2019;68:2044-56. [PMID: 30700543 DOI: 10.1136/gutjnl-2018-316091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
48 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 He L, Yuan H, Liang J, Hong J, Qu C. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. PLoS One 2020;15:e0233702. [PMID: 32442221 DOI: 10.1371/journal.pone.0233702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
51 Zinger A, Koren L, Adir O, Poley M, Alyan M, Yaari Z, Noor N, Krinsky N, Simon A, Gibori H, Krayem M, Mumblat Y, Kasten S, Ofir S, Fridman E, Milman N, Lübtow MM, Liba L, Shklover J, Shainsky-Roitman J, Binenbaum Y, Hershkovitz D, Gil Z, Dvir T, Luxenhofer R, Satchi-Fainaro R, Schroeder A. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. ACS Nano 2019;13:11008-21. [PMID: 31503443 DOI: 10.1021/acsnano.9b02395] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 23.7] [Reference Citation Analysis]
52 Ichimura M, Masuzumi M, Kawase M, Sakaki M, Tamaru S, Nagata Y, Tanaka K, Suruga K, Tsuneyama K, Matsuda S, Omagari K. A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. J Nutr Biochem 2017;40:62-9. [PMID: 27863346 DOI: 10.1016/j.jnutbio.2016.10.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
53 Messner S, Fredriksson L, Lauschke VM, Roessger K, Escher C, Bober M, Kelm JM, Ingelman-Sundberg M, Moritz W. Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues. Appl In Vitro Toxicol 2018;4:1-12. [PMID: 32953943 DOI: 10.1089/aivt.2017.0022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
54 Wu Y, Cowin G, Moonshi SS, Tran HDN, Fithri NA, Whittaker AK, Zhang R, Ta HT. Engineering chitosan nano-cocktail containing iron oxide and ceria: A two-in-one approach for treatment of inflammatory diseases and tracking of material delivery. Mater Sci Eng C Mater Biol Appl 2021;131:112477. [PMID: 34857262 DOI: 10.1016/j.msec.2021.112477] [Reference Citation Analysis]
55 Zhang MF, Liu YX, Jiang KY, Niu HM, Jiang JL, Dong ST, Wang X, Wang DF, Meng SN. Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin. Phytomedicine 2019;52:264-71. [PMID: 30599907 DOI: 10.1016/j.phymed.2018.06.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. Drug Des Devel Ther 2018;12:1837-53. [PMID: 29970958 DOI: 10.2147/DDDT.S162950] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
57 Xue LY, Jiang ZY, Fu TT, Wang QM, Zhu YL, Dai M, Wang WP, Yu JH, Ding H. Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis.Eur Radiol. 2020;30:2973-2983. [PMID: 31965257 DOI: 10.1007/s00330-019-06595-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
58 Zhao Z, Li Y, Jain A, Chen Z, Liu H, Jin W, Cheng K. Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells. Nanomedicine 2018;14:51-61. [PMID: 28890106 DOI: 10.1016/j.nano.2017.08.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
59 Athwal VS, Scott JA, Fitzpatrick E, Rowland M. Emerging clinical perspectives in cystic fibrosis liver disease. Curr Opin Pulm Med 2021;27:593-9. [PMID: 34482340 DOI: 10.1097/MCP.0000000000000824] [Reference Citation Analysis]
60 Hefler J, Marfil-Garza BA, Pawlick RL, Freed DH, Karvellas CJ, Bigam DL, Shapiro AMJ. Preclinical models of acute liver failure: a comprehensive review. PeerJ 2021;9:e12579. [PMID: 34966588 DOI: 10.7717/peerj.12579] [Reference Citation Analysis]
61 El-Gendy ZA, Ramadan A, El-Batran SA, Ahmed RF, El-Marasy SA, Abd El-Rahman SS, Youssef S. Carvacrol hinders the progression of hepatic fibrosis via targeting autotaxin and thioredoxin in thioacetamide-induced liver fibrosis in rat. Hum Exp Toxicol 2021;:9603271211026729. [PMID: 34155936 DOI: 10.1177/09603271211026729] [Reference Citation Analysis]
62 Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 2020;155:104720. [PMID: 32092405 DOI: 10.1016/j.phrs.2020.104720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
63 Gregolin CS, do Nascimento M, Borges de Souza SL, Ferreira Mota GA, Bomfim GF, de Azevedo Melo Luvizotto R, Sugizaki MM, Zanati Bazan SG, Salomé de Campos DH, Dias MC, Correa CR, Cicogna AC, Ferreira do Nascimento A. Myocardial Dysfunction in Cirrhotic Cardiomyopathy is Associated with Alterations of Phospholamban Phosphorylation and IL-6 Levels. Arch Med Res 2021;52:284-93. [PMID: 33220932 DOI: 10.1016/j.arcmed.2020.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
64 Mostafa RE, Shaffie NM, Allam RM. Panax Ginseng alleviates thioacetamide-induced liver injury in ovariectomized rats: Crosstalk between inflammation and oxidative stress. PLoS One 2021;16:e0260507. [PMID: 34843587 DOI: 10.1371/journal.pone.0260507] [Reference Citation Analysis]
65 Zhang H, Zahid A, Ismail H, Tang Y, Jin T, Tao J. An overview of disease models for NLRP3 inflammasome over-activation. Expert Opin Drug Discov 2021;16:429-46. [PMID: 33131335 DOI: 10.1080/17460441.2021.1844179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
66 El-Gendy ZA, El-Marasy SA, Ahmed RF, El-Batran SA, Abd El-Rahman SS, Ramadan A, Youssef SAH. Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats. Heliyon 2021;7:e07159. [PMID: 34159266 DOI: 10.1016/j.heliyon.2021.e07159] [Reference Citation Analysis]
67 Dawood RM, El-Meguid MA, Ibrahim MK, Bader El Din NG, Barakat A, El-Wakeel K, Alla MDAA, Wu GY, El Awady MK. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018;664:58-69. [PMID: 29684485 DOI: 10.1016/j.gene.2018.04.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
68 Romualdo GR, Grassi TF, Goto RL, Tablas MB, Bidinotto LT, Fernandes AAH, Cogliati B, Barbisan LF. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features. Toxicol Lett 2017;281:84-94. [PMID: 28943392 DOI: 10.1016/j.toxlet.2017.09.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
69 Vasse GF, Nizamoglu M, Heijink IH, Schlepütz M, van Rijn P, Thomas MJ, Burgess JK, Melgert BN. Macrophage-stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives. J Pathol 2021;254:344-57. [PMID: 33506963 DOI: 10.1002/path.5632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Bolt HM. Highlight report: The pseudolobule in liver fibrosis. EXCLI J 2017;16:1321-2. [PMID: 29333134 DOI: 10.17179/excli2017-1038] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong LY, Ye D, Lam KSL, Song E, Wang C, Xu A, Hoo RLC. Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Adv Sci (Weinh) 2021;8:e2003721. [PMID: 34105268 DOI: 10.1002/advs.202003721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S. Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α. Theranostics 2018;8:610-26. [PMID: 29344293 DOI: 10.7150/thno.22237] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
73 Ge S, Xiong Y, Wu X, Xie J, Liu F, He J, Xiang T, Cheng N, Lai L, Zhong Y. Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis. Biomed Pharmacother 2017;92:942-51. [PMID: 28618656 DOI: 10.1016/j.biopha.2017.05.142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Cai S, Wu L, Yuan S, Liu G, Wang Y, Fang L, Xu D. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur J Pharmacol 2021;898:173982. [PMID: 33647257 DOI: 10.1016/j.ejphar.2021.173982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Liu Y, Cavallaro PM, Kim BM, Liu T, Wang H, Kühn F, Adiliaghdam F, Liu E, Vasan R, Samarbafzadeh E, Farber MZ, Li J, Xu M, Mohad V, Choi M, Hodin RA. A role for intestinal alkaline phosphatase in preventing liver fibrosis. Theranostics 2021;11:14-26. [PMID: 33391458 DOI: 10.7150/thno.48468] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Li Y, Jin C, Shen M, Wang Z, Tan S, Chen A, Wang S, Shao J, Zhang F, Zhang Z, Zheng S. Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic Biol Med 2020;160:845-59. [PMID: 32947011 DOI: 10.1016/j.freeradbiomed.2020.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yu Q, Cheng P, Wu J, Guo C. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med 2021;25:1645-60. [PMID: 33438347 DOI: 10.1111/jcmm.16267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Inoue T, Ishizaka Y, Sasaki E, Lu J, Mineshige T, Yanase M, Sasaki E, Shimoda M. Thioacetamide-induced hepatic fibrosis in the common marmoset. Exp Anim 2018;67:321-7. [PMID: 29467352 DOI: 10.1538/expanim.17-0156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
81 Yasmin A, Regan DP, Schook LB, Gaba RC, Schachtschneider KM. Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model. Biochimie 2021;182:73-84. [PMID: 33444661 DOI: 10.1016/j.biochi.2020.12.022] [Reference Citation Analysis]
82 Park YJ, An HT, Park JS, Park O, Duh AJ, Kim K, Chung KH, Lee KC, Oh Y, Lee S. Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells. Sci Rep 2020;10:14756. [PMID: 32901093 DOI: 10.1038/s41598-020-71688-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Wang PW, Hung YC, Wu TH, Chen MH, Yeh CT, Pan TL. Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis. Oncotarget 2017;8:88951-64. [PMID: 29179490 DOI: 10.18632/oncotarget.21627] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
84 Henderson JM, Zhang HE, Polak N, Gorrell MD. Hepatocellular carcinoma: Mouse models and the potential roles of proteases. Cancer Lett 2017;387:106-13. [PMID: 27045475 DOI: 10.1016/j.canlet.2016.03.047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
85 Fukuda A, Sasao M, Asakawa E, Narita S, Hisano M, Suruga K, Ichimura M, Tsuneyama K, Tanaka K, Omagari K. Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats. Pathology - Research and Practice 2019;215:152599. [DOI: 10.1016/j.prp.2019.152599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
86 Mak K, Tan J, Marappan P, Balijepalli MK, Choudhury H, Ramamurthy S, Pichika MR. Galangin’s potential as a functional food ingredient. Journal of Functional Foods 2018;46:490-503. [DOI: 10.1016/j.jff.2018.04.054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
87 Wang H, Che J, Cui K, Zhuang W, Li H, Sun J, Chen J, Wang C. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo. Phytomedicine 2021;88:153609. [PMID: 34126414 DOI: 10.1016/j.phymed.2021.153609] [Reference Citation Analysis]
88 Fernández-Colino A, Iop L, Ventura Ferreira MS, Mela P. Fibrosis in tissue engineering and regenerative medicine: treat or trigger? Adv Drug Deliv Rev 2019;146:17-36. [PMID: 31295523 DOI: 10.1016/j.addr.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
89 Dai C, Yusuf A, Sun H, Shu G, Deng X. A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade. Phytomedicine 2021;93:153746. [PMID: 34634746 DOI: 10.1016/j.phymed.2021.153746] [Reference Citation Analysis]
90 Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22:10512-10522. [PMID: 28082803 DOI: 10.3748/wjg.v22.i48.10512.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Abd Elmaaboud M, Khattab H, Shalaby S. Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice. Can J Physiol Pharmacol 2021;99:294-302. [PMID: 32726558 DOI: 10.1139/cjpp-2020-0049] [Reference Citation Analysis]
92 Oates JR, McKell MC, Moreno-Fernandez ME, Damen MSMA, Deepe GS Jr, Qualls JE, Divanovic S. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Front Immunol 2019;10:2893. [PMID: 31921154 DOI: 10.3389/fimmu.2019.02893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
93 Li X, Liu Y, Yue W, Tan Y, Wang H, Zhang L, Chen J. A Compound of Chinese Herbs Protects against Alcoholic Liver Fibrosis in Rats via the TGF-β1/Smad Signaling Pathway. Evid Based Complement Alternat Med 2019;2019:9121347. [PMID: 31118972 DOI: 10.1155/2019/9121347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Lee YH, Son JY, Kim KS, Park YJ, Kim HR, Park JH, Kim KB, Lee KY, Kang KW, Kim IS, Kacew S, Lee BM, Kim HS. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int J Mol Sci 2019;20:E3709. [PMID: 31362375 DOI: 10.3390/ijms20153709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
95 Kuznietsova H, Dziubenko N, Hurmach V, Chereschuk I, Motuziuk O, Ogloblya O, Prylutskyy Y. Water-Soluble Pristine C60 Fullerenes Inhibit Liver Fibrotic Alteration and Prevent Liver Cirrhosis in Rats. Oxid Med Cell Longev 2020;2020:8061246. [PMID: 32148657 DOI: 10.1155/2020/8061246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
96 Tang G, Seume N, Häger C, Kumstel S, Abshagen K, Bleich A, Vollmar B, Talbot SR, Zhang X, Zechner D. Comparing distress of mouse models for liver damage. Sci Rep 2020;10:19814. [PMID: 33188220 DOI: 10.1038/s41598-020-76391-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Chen Q, Zhang J, Zheng T, Chen H, Nie H, Zheng B, Gong Q. The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis. Parasit Vectors 2019;12:611. [PMID: 31888743 DOI: 10.1186/s13071-019-3866-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
98 Li M, Chen L, Gao Y, Li M, Wang X, Qiang L, Wang X. Recent advances targeting C-C chemokine receptor type 2 for liver diseases in monocyte/macrophage. Liver Int 2020;40:2928-36. [PMID: 33025657 DOI: 10.1111/liv.14687] [Reference Citation Analysis]
99 Wang K, Guo Z, Bao Y, Pang Y, Li Y, He H, Song D. Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents. Molecules 2020;25:E4977. [PMID: 33121156 DOI: 10.3390/molecules25214977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Zhou J, Zhang X, Wan L, Yu J, Li T, Lu Z, Fang N, Sun L, Ye F. Zi Qi Decoction Alleviates Liver Fibrosis by Inhibiting the Toll-Like Receptor 4 (TLR4)-Related Nuclear Factor kappa b (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathways. Med Sci Monit 2021;27:e929438. [PMID: 33850093 DOI: 10.12659/MSM.929438] [Reference Citation Analysis]
101 Bissoondial TL, Han Y, Mullan S, Pabla AK, Spahn K, Shi S, Zheng L, Zhou P, Jiang K, Prakash N, Bhutkar S, Ali Q, Li J, Hu Z, Pellicano AJ, Goldberg ID, Narayan P. Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis. Diagnostics (Basel) 2020;10:E784. [PMID: 33020436 DOI: 10.3390/diagnostics10100784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Meier RPH, Meyer J, Montanari E, Lacotte S, Balaphas A, Muller YD, Clément S, Negro F, Toso C, Morel P, Buhler LH. Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner. Int J Mol Sci 2019;20:E1295. [PMID: 30875826 DOI: 10.3390/ijms20061295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
103 Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, da Silva TC, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers (Basel) 2021;13:5583. [PMID: 34771745 DOI: 10.3390/cancers13215583] [Reference Citation Analysis]
104 Schinagl M, Tomin T, Gindlhuber J, Honeder S, Pfleger R, Schittmayer M, Trauner M, Birner-Gruenberger R. Proteomic Changes of Activated Hepatic Stellate Cells. Int J Mol Sci 2021;22:12782. [PMID: 34884585 DOI: 10.3390/ijms222312782] [Reference Citation Analysis]
105 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
106 Yan L, Zhang X, Fu J, Liu Q, Lei X, Cao Z, Zhang J, Shao Y, Tong Q, Qin W, Liu X, Liu C, Liu Z, Li Z, Lu J, Xu X. Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis. Biochem Biophys Res Commun 2021;558:86-93. [PMID: 33906111 DOI: 10.1016/j.bbrc.2021.04.065] [Reference Citation Analysis]
107 Crespo Yanguas S, Willebrords J, Maes M, da Silva TC, Veloso Alves Pereira I, Cogliati B, Zaidan Dagli ML, Vinken M. Connexins and pannexins in liver damage. EXCLI J 2016;15:177-86. [PMID: 27065778 DOI: 10.17179/excli2016-119] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
108 Vilas-Boas V, Gijbels E, Leroy K, Pieters A, Baze A, Parmentier C, Vinken M. Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. Int J Mol Sci 2021;22:11005. [PMID: 34681664 DOI: 10.3390/ijms222011005] [Reference Citation Analysis]
109 Kim SK, Kim YH, Park S, Cho SW. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling. Acta Biomater 2021:S1742-7061(21)00143-4. [PMID: 33711526 DOI: 10.1016/j.actbio.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Jiang M, Cui BW, Wu YL, Zhang Y, Shang Y, Liu J, Yang HX, Qiao CY, Zhan ZY, Ye H, Jin Q, Nan JX, Lian LH. P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells. Toxicol Lett 2020;333:22-32. [PMID: 32721574 DOI: 10.1016/j.toxlet.2020.07.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
111 Wang X, Hu Y, Lu X, Cai Y, Shu J. Quantitative T2 mapping of rats with chronic hepatitis. Exp Ther Med 2021;21:225. [PMID: 33603834 DOI: 10.3892/etm.2021.9656] [Reference Citation Analysis]
112 Zhou T, Kyritsi K, Wu N, Francis H, Yang Z, Chen L, O'Brien A, Kennedy L, Ceci L, Meadows V, Kusumanchi P, Wu C, Baiocchi L, Skill NJ, Saxena R, Sybenga A, Xie L, Liangpunsakul S, Meng F, Alpini G, Glaser S. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC). EBioMedicine 2019;48:130-42. [PMID: 31522982 DOI: 10.1016/j.ebiom.2019.09.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
113 Ghallab A. Highlight report: Monitoring cytochrome P450 activities in living hepatocytes. EXCLI J 2017;16:1330-1. [PMID: 29333138 DOI: 10.17179/excli2017-1039] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
114 Carmona-Hidalgo B, González-Mariscal I, García-Martín A, Prados ME, Ruiz-Pino F, Appendino G, Tena-Sempere M, Muñoz E. Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. Phytomedicine 2021;81:153426. [PMID: 33341026 DOI: 10.1016/j.phymed.2020.153426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol 2018;29:14-21. [PMID: 29391303 DOI: 10.5152/tjg.2018.17330] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 14.8] [Reference Citation Analysis]
116 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
117 Liao K, Pellicano AJ, Jiang K, Prakash N, Li J, Bhutkar S, Hu Z, Ali Q, Goldberg ID, Narayan P. Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision Medicine. ACS Omega 2020;5:18465-71. [PMID: 32743224 DOI: 10.1021/acsomega.0c02350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Hassan HM, Cai Q, Liang X, Xin J, Ren K, Jiang J, Shi D, Lu Y, Li T, Shang Y, He L, Chen X, Sun S, Li P, Guo B, Chen J, Yang H, Hu W, Chen X, Li J. Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats. Life Sci Alliance 2022;5:e202101189. [PMID: 34853163 DOI: 10.26508/lsa.202101189] [Reference Citation Analysis]
119 Hartimath SV, Boominathan R, Soh V, Cheng P, Deng X, Chong YC, Yong FF, Tan PW, Han W, Robins EG, Goggi JL. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). Contrast Media Mol Imaging 2019;2019:6298128. [PMID: 31866798 DOI: 10.1155/2019/6298128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Van Campenhout R, Crespo Yanguas S, Cooreman A, Gijbels E, Leroy K, Vilas-Boas V, Devoogdt N, Muyldermans S, Cogliati B, Vinken M. Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation. Biomolecules 2019;9:E636. [PMID: 31652629 DOI: 10.3390/biom9100636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
121 Cai Y, Huang M, Wang X, Lu X, Luo L, Shu J. Quantitative analysis of susceptibility-weighted magnetic resonance imaging in chronic hepatitis in rats. Magnetic Resonance Imaging 2018;54:71-6. [DOI: 10.1016/j.mri.2018.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
122 Liu W, Hou T, Zhang X, He H. TGF-β1/Smad7 signaling pathway and cell apoptosis: Two key aspects of Selenium-biofortified soybean peptide attenuating liver fibrosis. Journal of Functional Foods 2019;63:103583. [DOI: 10.1016/j.jff.2019.103583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
123 El-Baz FK, Salama AAA, Hussein RA. Dunaliella salina microalgae oppose thioacetamide-induced hepatic fibrosis in rats. Toxicol Rep 2020;7:36-45. [PMID: 31879596 DOI: 10.1016/j.toxrep.2019.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]